OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
4.910
+0.160 (3.37%)
Dec 20, 2024, 4:00 PM EST - Market closed
OptimizeRx Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -24.17 | -17.57 | -11.44 | 0.38 | -2.21 | -3.14 | Upgrade
|
| Depreciation & Amortization | 4.15 | 2.4 | 2.02 | 2.09 | 2.08 | 1.28 | Upgrade
|
| Other Amortization | 0.85 | 0.21 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 2.14 | 2.14 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 14.23 | 6.74 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 11.16 | 13.72 | 15.75 | 5.49 | 3.17 | 2.26 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.32 | 0.67 | 0.36 | 0.08 | 0.2 | 0.08 | Upgrade
|
| Other Operating Activities | -1.63 | - | - | -0.12 | 0.14 | -0.26 | Upgrade
|
| Change in Accounts Receivable | 0.24 | -8.71 | 2.28 | -6.99 | -10.67 | -0.63 | Upgrade
|
| Change in Accounts Payable | 0.07 | -1.32 | 0.94 | -0.01 | 0.13 | -0.05 | Upgrade
|
| Change in Unearned Revenue | 0.52 | -0.07 | -1.23 | 1.1 | -0.29 | -0.03 | Upgrade
|
| Change in Other Net Operating Assets | -2.72 | 2.25 | 1.96 | -1.29 | 1.14 | -1.17 | Upgrade
|
| Operating Cash Flow | -1.57 | -7.24 | 10.65 | 0.73 | -6.31 | -1.66 | Upgrade
|
| Operating Cash Flow Growth | - | - | 1367.43% | - | - | - | Upgrade
|
| Capital Expenditures | -0.1 | -0.09 | -0.08 | -0.1 | -0.07 | -0.09 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | 0.01 | - | - | - | - | Upgrade
|
| Cash Acquisitions | -82.95 | -82.95 | -2 | - | - | -8.99 | Upgrade
|
| Divestitures | 2.54 | 2.54 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | 0.55 | -0.78 | -0.16 | -0.39 | -0.06 | -1.5 | Upgrade
|
| Investment in Securities | 53.62 | 55.93 | -55.93 | - | - | - | Upgrade
|
| Investing Cash Flow | -26.33 | -25.34 | -58.18 | -0.49 | -0.12 | -10.58 | Upgrade
|
| Long-Term Debt Issued | - | 37.73 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -1.71 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 34.52 | 36.02 | - | - | - | - | Upgrade
|
| Issuance of Common Stock | - | - | 1.07 | 80.29 | 2.49 | 23.88 | Upgrade
|
| Repurchase of Common Stock | -0.72 | -7.8 | -20.02 | - | - | - | Upgrade
|
| Other Financing Activities | 0.3 | - | - | -6.36 | -4.39 | -1.7 | Upgrade
|
| Financing Cash Flow | 34.1 | 28.22 | -18.95 | 73.92 | -1.9 | 22.18 | Upgrade
|
| Net Cash Flow | 6.2 | -4.36 | -66.47 | 74.16 | -8.34 | 9.94 | Upgrade
|
| Free Cash Flow | -1.67 | -7.33 | 10.57 | 0.63 | -6.38 | -1.75 | Upgrade
|
| Free Cash Flow Growth | - | - | 1589.75% | - | - | - | Upgrade
|
| Free Cash Flow Margin | -1.89% | -10.24% | 16.93% | 1.02% | -14.73% | -7.11% | Upgrade
|
| Free Cash Flow Per Share | -0.09 | -0.43 | 0.59 | 0.04 | -0.43 | -0.13 | Upgrade
|
| Levered Free Cash Flow | 5.79 | -2.4 | 14.86 | -1.4 | -5.84 | 0.57 | Upgrade
|
| Unlevered Free Cash Flow | 8.81 | -1.7 | 14.86 | -1.4 | -5.84 | 0.57 | Upgrade
|
| Change in Net Working Capital | 2.3 | 8.69 | -5.02 | 8.72 | 10.14 | -0.29 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.